Current Problems in Cancer
Volume 32, Issue 1 , Pages 7-34 , January 2008

Rhabdomyosarcoma

  • Arnold C. Paulino, MD

      Affiliations

    • Associate Professor, Baylor College of Medicine, Department of Radiology, Section of Radiation Oncology, The Methodist Hospital, Department of Radiology, Division of Radiation Oncology, Houston, Texas
    • ,
  • Mehmet Fatih Okcu, MD, MPH

      Affiliations

    • Assistant Professor, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

References 

  1. Ries LAG, Smith MA, Burney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER Program. National Cancer Institute, SEER Program, NIH, 1999; Pub No. 99-4649.
  2. Stiller CA, Parkin DM. International variations in the incidence of childhood soft-tissue sarcomas. Paediatr Perinat Epidemiol. 1994;8:107–119
  3. Ruymann FB, Maddux HR, Ragab A, et al. Congenital anomalies associated with rhabdomyosarcoma: an autopsy study of 115 cases (A report from the Intergroup Rhabdomyosarcoma Study Committee (representing the Children’s Cancer Study Group, the Pediatric Oncology Group, the United Kingdom Children’s Cancer Study Group and the Pediatric Intergroup Statistical Center)). Med Pediatr Oncol. 1988;16:33–39
  4. Hennekam RC. Costello syndrome: an overview. Am J Med Genet. 2003;117C:42–48
  5. Miller RW, Rubinstein JH. Tumors in Rubinstein-Taybi syndrome. Am J Med Genet. 1995;56:112–115
  6. Sung L, Anderson JR, Arndt C, et al. Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Pediatr. 2004;144:666–668
  7. Diller L, Sexsmith E, Gottlieb A, et al. Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma. J Clin Invest. 1995;95:1606–1611
  8. Grufferman S, Schwartz AG, Ruymann FB, et al. Parents’ use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control. 1993;4:217–224
  9. Hicks N, Zack M, Caldwell GG, et al. Childhood cancer and occupational radiation exposure in parents. Cancer. 1984;53:1637–1643
  10. Parham DM, Webber B, Holt H, et al. Immunohistochemical study of childhood rhabdomyosarcomas and related neoplasms. Cancer. 1991;67:3072–3080
  11. Dias P, Parham DM, Shapiro DN, et al. Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma. Am J Pathol. 1990;137:1283–1291
  12. Crist WM, Anderson JR, Meza JL, et al. Intergroup Rhabdomyosarcoma Study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–3102
  13. Scrable HJ, Witte DP, Lampkin BC, et al. Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature. 1987;329:645–647
  14. Fredericks WJ, Galili N, Mukhopadhyay S, et al. The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcoma is a more potent transcriptional activator than PAX3. Mol Cell Biol. 1995;15:1522–1535
  15. Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusios are prognostic indicators in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol. 2002;20:2672–2679
  16. Newton WA, Soule EH, Hamoudi AB, et al. Histopathology of childhood sarcomas, Intergroup Rhabdomyosarcoma Studies I and II: clinicopathologic correlation. J Clin Oncol. 1988;6:67–75
  17. Oberlin O, Rey A, Anderson J, et al. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment: results of an international workshop. J Clin Oncol. 2001;19:197–204
  18. Orbach D, Brisse H, Helfre S, et al. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary. Expert Opin Pharmacother. 2003;4:2165–2174
  19. Benk V, Rodary C, Donaldson SS, et al. Parameningeal rhabdomyosarcoma: results of an international workshop. Int J Radiat Oncol Biol Phys. 1996;36:533–540
  20. Paulino AC. Role of radiation therapy in parameningeal rhabdomyosarcoma. Cancer Invest. 1999;17:223–230
  21. Wharam M, Beltangady MS, Heyn RM, et al. Pediatric orofacial and laryngopharyngeal rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study report. Arch Otolaryngol Head Neck Surg. 1987;113:1225–1227
  22. Walterhouse DO, Pappo AS, Baker KS, et al. Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer. 2001;92:3135–3146
  23. Lawrence W, Hays D, Heyn R, et al. Lymphatic metastases with childhood rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. Cancer. 1987;60:910–915
  24. Hays DM, Raney RB, Lawrence W, et al. Bladder and prostatic tumors in the Intergroup Rhabdomyosarcoma Study (IRS-I). Cancer. 1982;50:1472–1482
  25. Maurer H, Gehan E, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer. 1993;71:1904–1923
  26. Breneman JC, Wiener ES. Issues in the local control of rhabdomyosarcoma. Med Pediatr Oncol. 2000;35:104–109
  27. Leuschner I, Newton WA, Schmidt D, et al. Spindle cell variants of embryonal rhabdomyosarcoma in the paratesticular region (A report of the Intergroup Rhabdomyosarcoma Study). Am J Surg Pathol. 1993;17:221–230
  28. Martelli H, Oberlin O, Rey A, et al. Conservative treatment for girls with nonmetastatic rhabdomyosarcoma of the genital tract: a report from the study committee of the International Society of Pediatric Oncology. J Clin Oncol. 1999;17:2117–2122
  29. Copeland LJ, Sneige N, Stringer A, et al. Alveolar rhabdomyosarcoma of the female genitalia. Cancer. 1985;56:849–855
  30. Heyn R, Beltangady M, Hays D, et al. Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1989;7:200–207
  31. Raney RB, Ragab AH, Ruymann FB, et al. Soft-tissue sarcoma of the trunk in childhood (Results of the Intergroup Rhabdomyosarcoma Study). Cancer. 1982;49:2612–2616
  32. Hays DM, Donaldson SS, Shimada H, et al. Primary and metastatic rhabdomyosarcoma in the breast: neoplasms of adolescent females: a report from the Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol. 1997;29:181–189
  33. Ortega JA, Wharam M, Gehan EA, et al. Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: a report of the Intergroup Rhabdomyosarcoma study. J Clin Oncol. 1991;9:796–801
  34. Beech TR, Moss RL, Anderson JA, et al. What comprises appropriate therapy for children/adolescents with rhabdomyosarcoma arising in the abdominal wall? (A report from the Intergroup Rhabdomyosarcoma Study Group). J Pediatr Surg. 1999;34:668–671
  35. Raney RB, Soner JA, Walterhouse DO, et al. Results of treatment of fifty-six patients with localized retroperitoneal and pelvic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study-IV, 1991-1997. Pediatr Blood Cancer. 2004;42:618–625
  36. Ruymann FB, Raney RB, Crist WM, et al. Rhabdomyosarcoma of the biliary tree in childhood (A Report from the Intergroup Rhabdomyosarcoma Study). Cancer. 1985;56:575–581
  37. Spunt SL, Anderson JR, Teot LA, et al. Routine brain imaging is unwarranted in asymptomatic patients with rhabdomyosarcoma arising outside the head and neck region that is metastatic at diagnosis: a report from the Intergroup Rhabdomyosarcoma Study Group. Cancer. 2001;92:121–125
  38. Breneman JC, Lyden E, Pappo AS, et al. Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2003;21:78–84
  39. Paulino AC, Nguyen TX, Barker JL. Brain metastasis in children with sarcoma, neuroblastoma and Wilms’ tumor. Int J Radiat Oncol Biol Phys. 2003;57:177–183
  40. Raney RB, Maurer HM, Anderson JR, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): major lessons from the IRS-I through IRS-IV studies as a background for the current IRS-V treatment protocols. Sarcoma. 2001;5:9–15
  41. Ferrari A, Casanova M, Bisogno G, et al. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer. 2003;97:2597–2604
  42. Simon JH, Paulino AC, Ritchie JM, et al. Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma. 2003;7:1–7
  43. Esnaola NF, Rubin BP, Baldini EH, et al. Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma. Ann Surg. 2001;234:215–223
  44. Hawkins WG, Hoos A, Antonescu CR, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001;91:794–803
  45. Little DJ, Ballo MT, Zagars GK, et al. Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer. 2002;95:377–388
  46. Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in adults: a retrospective analysis of 171 patients treated at a single institution. Cancer. 2003;98:571–580
  47. Schalow EL, Broecker BH. Role of surgery in children with rhabdomyosarcoma. Med Pediatr Oncol. 2003;41:1–6
  48. Hugosson CO, Nyman RS, Cappelen-Smith JM, et al. Ultrasound-guided biopsy of abdominal and pelvic lesions in children (A comparison between fine needle aspiration and 1.2 mm needle core biopsy). Pediatr Radiol. 1999;29:31–36
  49. Blakely ML, Lobe TE, Anderson JR, et al. Does debulking improve survival rate in advanced-stage retroperitoneal embryonal rhabdomyosarcoma?. J Pediatr Surg. 1999;34:736–742
  50. Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging: prognostic factors and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg. 2000;35:317–321
  51. Hays DM, Lawrence W, Crist WM, et al. Partial cystectomy in the management of rhabdomyosarcoma pf the bladder: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg. 1990;25:719–723
  52. Blatt J, Snyderman C, Wollman MR, et al. Delayed resection in the management of non-orbital rhabdomyosarcoma of the head and neck in childhood. Med Pediatr Oncol. 1997;29:294–298
  53. Hays DM, Raney RB, Crist WM, et al. Secondary surgical procedures to evaluate primary tumor status in patients with chemotherapy responsive Stage III and IV sarcomas: a report from the Intergroup Rhabdomyosarcoma Study. J Pediatr Surg. 1990;25:1100
  54. Stobbe GC, Dargeoaon HW. Embryonal rhabdomyosarcoma of the head and neck in children and adolescents. Cancer. 1950;3:826–836
  55. Donaldson SS, Meza J, Breneman JC, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma: a report from the IRSG. Int J Radiat Oncol Biol Phys. 2001;51:718–728
  56. Schuck A, Mattke AC, Schmidt B, et al. Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?. J Clin Oncol. 2004;22:143–149
  57. Wolden SL, Anderson JR, Crist WM, et al. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Studies I to III. J Clin Oncol. 1999;17:3468–3475
  58. Paulino AC, Simon JH, Zhen W, et al. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000;48:1489–1495
  59. Fiorollo A, Migliorati R, Vassallo P, et al. Radiation late effects in children treated for orbital rhabdomyosarcoma. Radiother Oncol. 1999;53:143–148
  60. Raney B, Heyn R, Hays DM, et al. Sequelae of treatment in 109 patients followed for 5 to 15 years after diagnosis of sarcoma of the bladder or prostate: a report from the Intergroup Rhabdomyosarcoma Study Committee. Cancer. 1993;71:2387–2394
  61. Paulino AC. Late effects of radiothery for pediatric extremity sarcomas. Int J Radiat Oncol Biol Phys. 2004;60:265–274
  62. Heyn R, Haeberlen V, Newton WA, et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol. 1993;11:262–270
  63. Michalski JM, Sur RK, Harms WB, et al. Three-dimensional conformal radiation therapy in pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys. 1995;33:985–991
  64. Wolden SL, La TH, LaQuaglia MP, et al. Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Cancer. 2003;97:179–185
  65. Paulino AC, Skwarchuk M. Intensity modulated radiation therapy in the treatment of children. Med Dosim. 2002;27:115–120
  66. Hug EB, Adams J, Fitzek M, et al. Fractionated, three-dimensional planning assisted proton-radiation therapy for orbital rhabdomyosarcoma: a novel technique. Int J Radiat Oncol Biol Phys. 2000;47:979–984
  67. Merchant TE, Parsh N, del Valle PL, et al. Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiat Oncol Biol Phys. 2000;46:427–432
  68. Nag S, Tippin D, Ruymann F. Long-term morbidity in children treated with fractionated high-dose-rate brachytherapy for soft tissue sarcomas. J Pediatr Hematol Oncol. 2003;25:448–452
  69. Crist W, Gehan EA, Ragab AH, et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 1995;13:610–630
  70. Maurer HM, Beltangady , Gehan EA, et al. The Intergroup Rhabdomyosarcoma Study-I (A final report). Cancer. 1988;61:209–220
  71. Dagher R, Helman L. Rhabdomyosarcoma: an overview. Oncologist. 1999;4:34–44
  72. Wilbur JR. Combination chemotherapy for embryonal rhabdomyosarcoma. Cancer Chemother Rep. 1974;58:281
  73. Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2000;18:2427–2434
  74. Furman WL, Stewart CF, Poquette CA, et al. Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol. 1999;17:1815–1824
  75. Blaney SM, Needle MN, Gillespie A, et al. Phase II trial of topotecan administered as a 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute and Children’s Cancer Group study. Clin Cancer Res. 1998;4:357–360
  76. Pappo AS, Lyden E, Breneman J, et al. Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an Intergroup Rhabdomyosarcoma Study. J Clin Oncol. 2001;19:213–219
  77. Knowles DM, Jakobiec FA, Potter GD, et al. Ophthalmic striated muscle neoplasms. Surv Ophthalmol. 1976;21:219–261
  78. Kodet R, Newton WA, Hamoudi AB, et al. Orbital rhabdomyosarcoma and related tumors in childhood: relationship of morphology to prognosis: an Intergroup Rhabdomyosarcoma Study. Med Pediatr Oncol. 1997;29:51–60
  79. Wharam M, Beltangady M, Hays D, et al. Localized orbital rhabdomyosarcoma: an interim report of the Intergroup Rhabdomyosarcoma Study Committee. Ophthalmology. 1987;94:251–254
  80. Carrie C, Freeman C. Are all consents really informed?. Int J Radiat Oncol Biol Phys. 2001;51:287
  81. Tefft M, Fernandez C, Donaldson M, et al. Incidence of meningeal involvement by rhabdomyosarcoma of the head and neck in children: a report from the Intergroup Rhabdomyosarcoma Study (IRS). Cancer. 1978;42:253–258
  82. Gasparini M, Lombardi F, Gianni MC, et al. Questionable role of CNS radioprophylaxis in the therapeutic management of childhood rhabdomyosarcoma. J Clin Oncol. 1990;8:1854–1857
  83. Michalski JM, Meza J, Breneman JC, et al. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV. Int J Radiat Oncol Biol Phys. 2004;59:1027–1038
  84. Paulino AC, Bauman N, Simon JH, et al. Local control of parameningeal rhabdomyosarcoma: outcomes in non-complete responders to chemoradiation. Med Pediatr Oncol. 2003;41:118–122
  85. Baker KS, Anderson JR, Link MP, et al. Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol. 2000;18:2427–2434
  86. Hays D. The management of rhabdomyosarcoma in children and young adults. World J Surg. 1980;4:15–28
  87. Hays D. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study. Semin Surg Oncol. 1993;9:520–523
  88. Arndt C, Rodeberg D, Breitfeld PP, et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? (Results from Intergroup Rhabdomyosarcoma Study IV). J Urol. 2004;171:2396–2403
  89. Yeung CK, Ward HC, Ransley PG, et al. Bladder and kidney function after cure of pelvic rhabdomyosarcoma in childhood. Br J Cancer. 1994;70:1000–1003
  90. Arndt CAS, Donaldson SS, Anderson JR, et al. What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract?. Cancer. 2001;91:2454–2468
  91. Andrassy RJ, Corpron CA, Hays D, et al. Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III. J Pediatr Surg. 1996;31:191–196
  92. Neville HL, Andrassy RJ, Lobe TE, et al. Preoperative staging, prognostic factors and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997). J Pediatr Surg. 2000;35:317–321
  93. McMulkin HM, Yanchar NL, Fernandez CV, et al. Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int. 2003;19:453–456
  94. Spunt SL, Lobe TE, Pappo AS, et al. Aggressive surgery is unwarranted for biliary tract rhabdomyosarcoma. J Pediatr Surg. 2000;35:309–316
  95. Raney RB, Crist WM, Maurer HM, et al. Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response: a report from the Intergroup Rhabdomyosarcoma Study I. Cancer. 1983;52:44–50
  96. Klingebiel T, Pertl U, Hess C, et al. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol. 1998;30:269–275
  97. Pappo AS, Anderson JR, Crist WM, et al. Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol. 1999;17:3487–3493

PII: S0147-0272(07)00071-2

doi: 10.1016/j.currproblcancer.2007.11.001

Current Problems in Cancer
Volume 32, Issue 1 , Pages 7-34 , January 2008

Article Tools

* Image Usage & Resolution